These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8016407)

  • 41. Diurnal variation in the effects of type A CCK receptor antagonist devazepide on meal patterns in rats.
    Castellanos DA; Reidelberger RD
    Ann N Y Acad Sci; 1994 Mar; 713():429-30. PubMed ID: 8185210
    [No Abstract]   [Full Text] [Related]  

  • 42. Hypolocomotion induced by peripheral or central injection of CCK in the mouse is blocked by the CCKA receptor antagonist devazepide but not by the CCKB receptor antagonist L-365,260.
    O'Neill MF; Dourish CT; Iversen SD
    Eur J Pharmacol; 1991 Feb; 193(2):203-8. PubMed ID: 2050197
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular mechanisms for the growth factor action of gastrin.
    Todisco A; Takeuchi Y; Urumov A; Yamada J; Stepan VM; Yamada T
    Am J Physiol; 1997 Oct; 273(4):G891-8. PubMed ID: 9357832
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cholecystokinin induces Fos expression in the brain of the Japanese quail.
    Boswell T; Li Q
    Horm Behav; 1998 Aug; 34(1):56-66. PubMed ID: 9735229
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Devazepide antagonizes the inhibitory effect of cholecystokinin on intake in sham-feeding rats.
    Melville LD; Smith GP; Gibbs J
    Pharmacol Biochem Behav; 1992 Nov; 43(3):975-7. PubMed ID: 1448494
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of cholecystokinin in the anorexia produced by duodenal delivery of peptone in rats.
    Woltman T; Reidelberger R
    Am J Physiol; 1999 Jun; 276(6):R1701-9. PubMed ID: 10362750
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.
    Boyle SJ; Tang KW; Woodruff GN; McKnight AT
    Br J Pharmacol; 1993 Aug; 109(4):913-7. PubMed ID: 8401944
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A CCK(A)-receptor antagonist administered to the neonate alters mother-infant interactions in the rat.
    Weller A; Dubson L
    Pharmacol Biochem Behav; 1998 Apr; 59(4):843-51. PubMed ID: 9586840
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors.
    Dourish CT; Rycroft W; Iversen SD
    Science; 1989 Sep; 245(4925):1509-11. PubMed ID: 2781294
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Total parenteral nutrition affects the tropic effect of cholecystokinin on the exocrine pancreas.
    Fan BG; Axelson J; Sternby B; Rehfeld J; Ihse I; Ekelund M
    Scand J Gastroenterol; 1997 Apr; 32(4):380-6. PubMed ID: 9140162
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of cholecystokinin in the anorexia produced by duodenal delivery of glucose in rats.
    Woltman T; Reidelberger R
    Am J Physiol; 1996 Dec; 271(6 Pt 2):R1521-8. PubMed ID: 8997348
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of CCK-A antagonist devazepide on inhibition of feeding by duodenal infusion of oleic acid in rats.
    Woltman TA; Reidelberger RD
    Ann N Y Acad Sci; 1994 Mar; 713():372-3. PubMed ID: 8185191
    [No Abstract]   [Full Text] [Related]  

  • 53. Hindbrain noradrenergic lesions attenuate anorexia and alter central cFos expression in rats after gastric viscerosensory stimulation.
    Rinaman L
    J Neurosci; 2003 Nov; 23(31):10084-92. PubMed ID: 14602823
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of dexfenfluramine on the transcriptional activation of CRF and its type 1 receptor within the paraventricular nucleus of the rat hypothalamus.
    Laflamme N; Bovetto S; Richard D; Rivest S
    Br J Pharmacol; 1996 Mar; 117(6):1021-34. PubMed ID: 8882592
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Estradiol enhances cholecystokinin-dependent lipid-induced satiation and activates estrogen receptor-alpha-expressing cells in the nucleus tractus solitarius of ovariectomized rats.
    Asarian L; Geary N
    Endocrinology; 2007 Dec; 148(12):5656-66. PubMed ID: 17823256
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activation of submucosal but not myenteric plexus of the gastrointestinal tract accompanies reduction of food intake by camostat.
    Raboin SJ; Reeve JR; Cooper MS; Green GM; Sayegh AI
    Regul Pept; 2008 Oct; 150(1-3):73-80. PubMed ID: 18620003
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Portacaval shunt increases the trophic effect of cholecystokinin on the rat pancreas.
    Nylander AG; Chen D; Rehfeld JF; Håkanson R
    Scand J Gastroenterol; 1993 Feb; 28(2):145-8. PubMed ID: 8441908
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of the CCK receptor antagonist MK-329 on food intake in pigs.
    Ebenezer IS; de la Riva C; Baldwin BA
    Physiol Behav; 1990 Jan; 47(1):145-8. PubMed ID: 2326329
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cholecystokinin and hypothalamic corticotrophin-releasing factor participate in endotoxin-induced hypophagia.
    Rorato R; Reis WL; Antunes-Rodrigues J; Elias LL
    Exp Physiol; 2011 Apr; 96(4):439-50. PubMed ID: 21239462
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cholecystokinin potentiates morphine anticonvulsant action through both CCK-A and CCK-B receptors.
    Legido A; Adler MW; Karkanias C; Geller EB; Bradley E; Greenstein JI; Grover WD
    Neuropeptides; 1995 Feb; 28(2):107-13. PubMed ID: 7746354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.